Utah Medical Products Inc... (UTMD)
NASDAQ: UTMD
· Real-Time Price · USD
55.83
-1.04 (-1.83%)
At close: Aug 15, 2025, 3:08 PM
Utah Medical Products Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 12.96M | 13.87M | 15.26M | 15.63M | 16.38M | 16.64M | 16.9M | 17.25M | 17.15M | 16.47M | 16.05M | 15.98M | 15.3M | 14.79M | 14.07M | 12.8M | 10.68M |
Depreciation & Amortization | 606K | 568K | 1.61M | 4.2M | 5.29M | 6.37M | 7.08M | 7.04M | 7.04M | 7.08M | 7.1M | 7.19M | 7.26M | 7.28M | 7.32M | 7.29M | 7.23M |
Stock-Based Compensation | 259K | 256K | 256K | 256K | 254K | 225K | 215K | 200K | 190K | 183K | 164K | 167K | 168K | 166K | 162K | 170K | 178K |
Other Working Capital | -1.96M | -1.84M | -2.01M | -1.13M | -1.29M | -1.38M | -911K | 649K | 1.12M | 647K | -12K | -730K | -463K | 207K | 934K | 462K | 1.09M |
Other Non-Cash Items | 1.45M | 1.46M | 1.55M | -2K | -24K | -23K | -6K | -9K | 29K | 36K | 53K | 76K | 64K | 63K | 30K | 23K | 21K |
Deferred Income Tax | -365K | -348K | -815K | -909K | -882K | -691K | -274K | -250K | -258K | -401K | -341K | -400K | -28K | -92K | -166K | -55K | -137K |
Change in Working Capital | -886K | -975K | -630K | -686K | -371K | -233K | -1.29M | -1.13M | -1.14M | -2.23M | -2.58M | -2.15M | -2.04M | -1.01M | 579K | 783K | 2.02M |
Operating Cash Flow | 14.02M | 14.83M | 17.23M | 18.49M | 20.64M | 22.28M | 22.63M | 23.1M | 23.02M | 21.15M | 20.45M | 20.86M | 20.72M | 21.2M | 21.99M | 21.01M | 20M |
Capital Expenditures | -171K | -9K | -90K | -413K | -618K | -639K | -587K | -722K | -624K | -818K | -1.03M | -789K | -779K | -552K | -353K | -371K | -416K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -231K | -204K | -204K | 22K | 27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -397K | -208K | -289K | -386K | -591K | -639K | -587K | -722K | -624K | -818K | -1.03M | -789K | -779K | -552K | -353K | -371K | -416K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -20.2M | -19.97M | -15.75M | -11.89M | -5.49M | -2.5M | -2.5M | -2.5M | -4.99M | -4.99M | -2.5M | -2.5M | n/a | n/a | 1K | -550K | -550K |
Dividend Paid | -4.19M | -4.26M | -4.29M | -4.31M | -4.3M | -4.28M | -4.26M | -4.24M | -4.23M | -3.16M | -10.46M | -10.45M | -10.43M | -11.46M | -4.13M | -4.12M | -4.11M |
Other Financial Acitivies | 294K | 390K | 390K | 426K | 192K | 117K | 248K | 232K | 176K | 174K | 43K | 212K | 211K | 281K | 357K | 371K | 399K |
Financial Cash Flow | -24.09M | -23.84M | -17.16M | -13.28M | -7.1M | -4.17M | -4.01M | -4.01M | -6.55M | -5.48M | -12.63M | -12.45M | -9.94M | -10.9M | -3.78M | -4.29M | -4.26M |
Net Cash Flow | -10.48M | -9.89M | 243K | 4.6M | 12.9M | 17.82M | 18.7M | 18.39M | 15.04M | 14.08M | 5.19M | 6.72M | 9.84M | 9.38M | 18.03M | 17.15M | 16.42M |
Free Cash Flow | 13.85M | 14.82M | 17.14M | 18.08M | 20.02M | 21.64M | 22.04M | 22.38M | 22.39M | 20.33M | 19.42M | 20.07M | 19.94M | 20.65M | 21.64M | 20.64M | 19.58M |